Appropriate Glycosylation of the Fms Gene Product is a Prerequisite for Its Transforming Potency

Overview

Journal EMBO J

Specialties Biotechnology
Molecular Biology

Date 1986 Apr 1

PMID 3086087

Citations 12

Authors

A Hadwiger

H Niemann

A Kabisch

H Bauer

T Tamura

Affiliations

Soon will be listed here.

Abstract

Processing inhibitors of N-linked glycans were used to determine whether correct glycosylation of the oncogene product gp140v-fms, encoded by the McDonough strain of feline sarcoma virus (SM-FeSV), is required to maintain the oncogenic properties of v-fms. SM-FeSV-transformed cells treated with the glucosidase-I inhibitors N-methyldeoxynojirimycin (MdN) or castanospermine synthesized predominantly a gp125v-fms species which had a normal half life. The molecule was transported to the plasma membrane and exhibited normal kinase activity as determined by autophosphorylation. However, although no significant change in cell morphology of the SM-FeSV-transformed cells was observed in the presence of castanospermine, growth of these cells became strictly serum-dependent. In addition, growth in soft agar was drastically retarded despite the presence of 10% calf serum, indicating that the transformed properties of the cells were altered. In contrast, swainsonine, an inhibitor of the processing alpha-mannosidase-II, had no effect. Cells transformed by the Snyder Theilen strain of FeSV were used to demonstrate that the altered proliferative properties were directly linked to the modified structure of the fms gene product. Our data suggest that the extracellular domain of gp140v-fms plays a role in regulating cell proliferation.

Citing Articles

Small molecule inhibitors of mammalian glycosylation.

Almahayni K, Spiekermann M, Fiore A, Yu G, Pedram K, Mockl L Matrix Biol Plus. 2022; 16:100108.

PMID: 36467541 PMC: 9713294. DOI: 10.1016/j.mbplus.2022.100108.

New castanospermine glycoside analogues inhibit breast cancer cell proliferation and induce apoptosis without affecting normal cells.

Allan G, Ouadid-Ahidouch H, Sanchez-Fernandez E, Risquez-Cuadro R, Garcia Fernandez J, Ortiz-Mellet C PLoS One. 2013; 8(10):e76411.

PMID: 24124558 PMC: 3790671. DOI: 10.1371/journal.pone.0076411.

Arbuscular mycorrhizal symbiosis and active ingredients of medicinal plants: current research status and prospectives.

Zeng Y, Guo L, Chen B, Hao Z, Wang J, Huang L Mycorrhiza. 2013; 23(4):253-65.

PMID: 23417725 DOI: 10.1007/s00572-013-0484-0.

Tyrosine phosphorylation of proteins in primary human myeloid leukemic cells stimulated by macrophage colony-stimulating factor: analysis by disease type and comparison with normal human hematopoietic cells.

Hagiwara S, Yagisawa M, Saeki K, Iki S, Urabe A, Mimura T Int J Hematol. 2001; 73(1):100-7.

PMID: 11372744 DOI: 10.1007/BF02981910.

Reduced contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V.

Demetriou M, Nabi I, Coppolino M, Dedhar S, Dennis J J Cell Biol. 1995; 130(2):383-92.

PMID: 7615638 PMC: 2199932. DOI: 10.1083/jcb.130.2.383.

References

Soderquist A, Carpenter G . Glycosylation of the epidermal growth factor receptor in A-431 cells. The contribution of carbohydrate to receptor function. J Biol Chem. 1984; 259(20):12586-94. View

Anderson S, Gonda M, Rettenmier C, Sherr C . Subcellular localization of glycoproteins encoded by the viral oncogene v-fms. J Virol. 1984; 51(3):730-41. PMC: 255838. DOI: 10.1128/JVI.51.3.730-741.1984. View

Roussel M, Rettenmier C, Look A, Sherr C . Cell surface expression of v-fms-coded glycoproteins is required for transformation. Mol Cell Biol. 1984; 4(10):1999-2009. PMC: 369016. DOI: 10.1128/mcb.4.10.1999-2009.1984. View

Gilmore T, DeClue J, Martin G . Protein phosphorylation at tyrosine is induced by the v-erbB gene product in vivo and in vitro. Cell. 1985; 40(3):609-18. DOI: 10.1016/0092-8674(85)90209-0. View

Hunter T . Cell-surface proteins. At last the insulin receptor. Nature. 1985; 313(6005):740-1. DOI: 10.1038/313740a0. View

Ullrich A, Bell J, Chen E, Herrera R, Petruzzelli L, Dull T . Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature. 1985; 313(6005):756-61. DOI: 10.1038/313756a0. View

Rettenmier C, Roussel M, Quinn C, Kitchingman G, Look A, Sherr C . Transmembrane orientation of glycoproteins encoded by the v-fms oncogene. Cell. 1985; 40(4):971-81. DOI: 10.1016/0092-8674(85)90357-5. View

Schlesinger S, Koyama A, Malfer C, Gee S, SCHLESINGER M . The effects of inhibitors of glucosidase I on the formation of Sindbis virus. Virus Res. 1985; 2(2):139-49. DOI: 10.1016/0168-1702(85)90244-8. View

Sherr C, Rettenmier C, Sacca R, Roussel M, Look A, Stanley E . The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell. 1985; 41(3):665-76. DOI: 10.1016/s0092-8674(85)80047-7. View

10.

Schmidt J, Beug H, Hayman M . Effects of inhibitors of glycoprotein processing on the synthesis and biological activity of the erb B oncogene. EMBO J. 1985; 4(1):105-12. PMC: 554157. DOI: 10.1002/j.1460-2075.1985.tb02323.x. View

11.

Repp R, Tamura T, Boschek C, Wege H, Schwarz R, Niemann H . The effects of processing inhibitors of N-linked oligosaccharides on the intracellular migration of glycoprotein E2 of mouse hepatitis virus and the maturation of coronavirus particles. J Biol Chem. 1985; 260(29):15873-9. PMC: 8039981. View

12.

Verbeek J, de Ruyter P, Bloemers H, Van de Ven W . Molecular cloning and characterization of feline cellular genetic sequences homologous to the oncogene of the McDonough strain of feline sarcoma virus. Virology. 1985; 141(2):322-7. DOI: 10.1016/0042-6822(85)90266-1. View

13.

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

14.

Barbacid M, Lauver A . Gene products of McDonough feline sarcoma virus have an in vitro-associated protein kinase that phosphorylates tyrosine residues: lack of detection of this enzymatic activity in vivo. J Virol. 1981; 40(3):812-21. PMC: 256692. DOI: 10.1128/JVI.40.3.812-821.1981. View

15.

Ek B, Westermark B, Wasteson A, Heldin C . Stimulation of tyrosine-specific phosphorylation by platelet-derived growth factor. Nature. 1982; 295(5848):419-20. DOI: 10.1038/295419a0. View

16.

Tushinski R, Oliver I, Guilbert L, Tynan P, Warner J, Stanley E . Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy. Cell. 1982; 28(1):71-81. DOI: 10.1016/0092-8674(82)90376-2. View

17.

Buhrow S, Cohen S, Staros J . Affinity labeling of the protein kinase associated with the epidermal growth factor receptor in membrane vesicles from A431 cells. J Biol Chem. 1982; 257(8):4019-22. View

18.

Kasuga M, Zick Y, Blithe D, Crettaz M, Kahn C . Insulin stimulates tyrosine phosphorylation of the insulin receptor in a cell-free system. Nature. 1982; 298(5875):667-9. DOI: 10.1038/298667a0. View

19.

Nishimura J, Huang J, Deuel T . Platelet-derived growth factor stimulates tyrosine-specific protein kinase activity in Swiss mouse 3T3 cell membranes. Proc Natl Acad Sci U S A. 1982; 79(14):4303-7. PMC: 346659. DOI: 10.1073/pnas.79.14.4303. View

20.

Anderson S, Furth M, Wolff L, Ruscetti S, Sherr C . Monoclonal antibodies to the transformation-specific glycoprotein encoded by the feline retroviral oncogene v-fms. J Virol. 1982; 44(2):696-702. PMC: 256314. DOI: 10.1128/JVI.44.2.696-702.1982. View